Characteristics | Total (%) | TS | PF | p value |
---|---|---|---|---|
Gender | 0.395 | |||
Male | 84(60.0) | 30(55.6) | 54(62.8) | |
Female | 56(40.0) | 24(44.4) | 32(37.2) | |
Age(years) | 0.028 | |||
≤65 | 86(61.4) | 27(50.0) | 59(68.6) | |
>65 | 54(38.6) | 27(50.0) | 27(31.4) | |
The length | 0.354 | |||
≤5 cm | 58(41.4) | 25(46.3) | 33(38.4) | |
>5 cm | 82(58.6) | 29(53.7) | 53(61.6) | |
Tumor location | 0.800 | |||
Upper | 33(23.6) | 11(20.4) | 22(25.6) | |
Middle | 92(65.7) | 38(70.4) | 54(62.8) | |
Lower | 15(11.7) | 5(9.2) | 10(11.6) | |
T stage | 0.026 | |||
T2 | 22(15.7) | 13(24.1) | 9(10.5) | |
T3 | 51(36.4) | 22(40.7) | 29(33.7) | |
T4 | 67(47.9) | 19(35.2) | 48(55.8) | |
N stage | 0.002 | |||
N0 | 68(48.6) | 35(64.8) | 33(38.4) | |
N1 | 72(51.4) | 19(35.2) | 53(61.6) | |
6th AJCC stage | 0.007 | |||
Iia | 43(30.7) | 24(44.4) | 19(22.1) | |
Iib | 7(5.0) | 4(7.4) | 3(3.5) | |
III | 90(64.3) | 26(48.2) | 64(74.4) | |
RT Dose | 0.809 | |||
≤66 Gy | 89(63.6) | 35(64.8) | 54(62.8) | |
≥67 Gy | 51(36.4) | 19(44.4) | 32(37.2) |